Global Covid-19 Vaccine Market Size, Share, Trends and Forecast 2022-2030

Market Analysis and Insights: Global Covid-19 Vaccine Market
A COVID-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (COVID-19). Although no vaccine has completed clinical trials, there are multiple attempts in progress to develop such a vaccine.

The genetic sequence of SARS-CoV-2, the coronavirus that causes COVID-19, was published on 11 January 2020, triggering intense global R&D activity to develop a vaccine against the disease. The scale of the humanitarian and economic impact of the COVID-19 pandemic is driving evaluation of next-generation vaccine technology platforms through novel paradigms to accelerate development, and the first COVID-19 vaccine candidate entered human clinical testing with unprecedented rapidity on 16 March 2020.

The global vaccine R&D effort in response to the COVID-19 pandemic is unprecedented in terms of scale and speed. Given the imperative for speed, there is an indication that vaccine could be available under emergency use or similar protocols by early 2021. This would represent a fundamental step change from the traditional vaccine development pathway, which takes on average over 10 years, even compared with the accelerated 5-year timescale for development of the first Ebola vaccine, and will necessitate novel vaccine development paradigms involving parallel and adaptive development phases, innovative regulatory processes and scaling manufacturing capacity.

The global Covid-19 Vaccine market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

North America is the largest consumption place, with a consumption market share nearly 53.8% in 2026, Europe is the second largest consumption place with the consumption market share of 24.61% in 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Covid-19 Vaccine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Covid-19 Vaccine market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Covid-19 Vaccine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Covid-19 Vaccine market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Covid-19 Vaccine market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Covid-19 Vaccine Breakdown Data by Type

DNA

Non-replicating Viral Vector

Protein Subunit

RNA

Others

Covid-19 Vaccine Breakdown Data by Application

Adults

Children

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

Moderna

CanSino Biologicals

Inovio Pharmaceuticals

Shenzhen Geno-Immune Medical Institute

GlaxoSmithKine

Pfizer

Johnson＆Johnson

Heat Biologics

Sanofi

1 Report Business Overview
1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Covid-19 Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 DNA

1.2.3 Non-replicating Viral Vector

1.2.4 Protein Subunit

1.2.5 RNA

1.2.6 Others

1.3 Market by Application

1.3.1 Global Covid-19 Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Adults

1.3.3 Children

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Covid-19 Vaccine Market Perspective (2017-2028)

2.2 Covid-19 Vaccine Growth Trends by Region

2.2.1 Covid-19 Vaccine Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Covid-19 Vaccine Historic Market Size by Region (2017-2022)

2.2.3 Covid-19 Vaccine Forecasted Market Size by Region (2023-2028)

2.3 Covid-19 Vaccine Market Dynamics

2.3.1 Covid-19 Vaccine Industry Trends

2.3.2 Covid-19 Vaccine Market Drivers

2.3.3 Covid-19 Vaccine Market Challenges

2.3.4 Covid-19 Vaccine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Covid-19 Vaccine Players by Revenue

3.1.1 Global Top Covid-19 Vaccine Players by Revenue (2017-2022)

3.1.2 Global Covid-19 Vaccine Revenue Market Share by Players (2017-2022)

3.2 Global Covid-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Covid-19 Vaccine Revenue

3.4 Global Covid-19 Vaccine Market Concentration Ratio

3.4.1 Global Covid-19 Vaccine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Vaccine Revenue in 2021

3.5 Covid-19 Vaccine Key Players Head office and Area Served

3.6 Key Players Covid-19 Vaccine Product Solution and Service

3.7 Date of Enter into Covid-19 Vaccine Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Vaccine Breakdown Data by Type

4.1 Global Covid-19 Vaccine Historic Market Size by Type (2017-2022)

4.2 Global Covid-19 Vaccine Forecasted Market Size by Type (2023-2028)

5 Covid-19 Vaccine Breakdown Data by Application

5.1 Global Covid-19 Vaccine Historic Market Size by Application (2017-2022)

5.2 Global Covid-19 Vaccine Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Covid-19 Vaccine Market Size (2017-2028)

6.2 North America Covid-19 Vaccine Market Size by Type

6.2.1 North America Covid-19 Vaccine Market Size by Type (2017-2022)

6.2.2 North America Covid-19 Vaccine Market Size by Type (2023-2028)

6.2.3 North America Covid-19 Vaccine Market Share by Type (2017-2028)

6.3 North America Covid-19 Vaccine Market Size by Application

6.3.1 North America Covid-19 Vaccine Market Size by Application (2017-2022)

6.3.2 North America Covid-19 Vaccine Market Size by Application (2023-2028)

6.3.3 North America Covid-19 Vaccine Market Share by Application (2017-2028)

6.4 North America Covid-19 Vaccine Market Size by Country

6.4.1 North America Covid-19 Vaccine Market Size by Country (2017-2022)

6.4.2 North America Covid-19 Vaccine Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Covid-19 Vaccine Market Size (2017-2028)

7.2 Europe Covid-19 Vaccine Market Size by Type

7.2.1 Europe Covid-19 Vaccine Market Size by Type (2017-2022)

7.2.2 Europe Covid-19 Vaccine Market Size by Type (2023-2028)

7.2.3 Europe Covid-19 Vaccine Market Share by Type (2017-2028)

7.3 Europe Covid-19 Vaccine Market Size by Application

7.3.1 Europe Covid-19 Vaccine Market Size by Application (2017-2022)

7.3.2 Europe Covid-19 Vaccine Market Size by Application (2023-2028)

7.3.3 Europe Covid-19 Vaccine Market Share by Application (2017-2028)

7.4 Europe Covid-19 Vaccine Market Size by Country

7.4.1 Europe Covid-19 Vaccine Market Size by Country (2017-2022)

7.4.2 Europe Covid-19 Vaccine Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Covid-19 Vaccine Market Size (2017-2028)

8.2 Asia-Pacific Covid-19 Vaccine Market Size by Type

8.2.1 Asia-Pacific Covid-19 Vaccine Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Covid-19 Vaccine Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Covid-19 Vaccine Market Share by Type (2017-2028)

8.3 Asia-Pacific Covid-19 Vaccine Market Size by Application

8.3.1 Asia-Pacific Covid-19 Vaccine Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Covid-19 Vaccine Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Covid-19 Vaccine Market Share by Application (2017-2028)

8.4 Asia-Pacific Covid-19 Vaccine Market Size by Region

8.4.1 Asia-Pacific Covid-19 Vaccine Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Covid-19 Vaccine Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Covid-19 Vaccine Market Size (2017-2028)

9.2 Latin America Covid-19 Vaccine Market Size by Type

9.2.1 Latin America Covid-19 Vaccine Market Size by Type (2017-2022)

9.2.2 Latin America Covid-19 Vaccine Market Size by Type (2023-2028)

9.2.3 Latin America Covid-19 Vaccine Market Share by Type (2017-2028)

9.3 Latin America Covid-19 Vaccine Market Size by Application

9.3.1 Latin America Covid-19 Vaccine Market Size by Application (2017-2022)

9.3.2 Latin America Covid-19 Vaccine Market Size by Application (2023-2028)

9.3.3 Latin America Covid-19 Vaccine Market Share by Application (2017-2028)

9.4 Latin America Covid-19 Vaccine Market Size by Country

9.4.1 Latin America Covid-19 Vaccine Market Size by Country (2017-2022)

9.4.2 Latin America Covid-19 Vaccine Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Covid-19 Vaccine Market Size (2017-2028)

10.2 Middle East & Africa Covid-19 Vaccine Market Size by Type

10.2.1 Middle East & Africa Covid-19 Vaccine Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Covid-19 Vaccine Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Covid-19 Vaccine Market Share by Type (2017-2028)

10.3 Middle East & Africa Covid-19 Vaccine Market Size by Application

10.3.1 Middle East & Africa Covid-19 Vaccine Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Covid-19 Vaccine Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Covid-19 Vaccine Market Share by Application (2017-2028)

10.4 Middle East & Africa Covid-19 Vaccine Market Size by Country

10.4.1 Middle East & Africa Covid-19 Vaccine Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Covid-19 Vaccine Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Moderna

11.1.1 Moderna Company Details

11.1.2 Moderna Business Overview

11.1.3 Moderna Covid-19 Vaccine Introduction

11.1.4 Moderna Revenue in Covid-19 Vaccine Business (2017-2022)

11.1.5 Moderna Recent Developments

11.2 CanSino Biologicals

11.2.1 CanSino Biologicals Company Details

11.2.2 CanSino Biologicals Business Overview

11.2.3 CanSino Biologicals Covid-19 Vaccine Introduction

11.2.4 CanSino Biologicals Revenue in Covid-19 Vaccine Business (2017-2022)

11.2.5 CanSino Biologicals Recent Developments

11.3 Inovio Pharmaceuticals

11.3.1 Inovio Pharmaceuticals Company Details

11.3.2 Inovio Pharmaceuticals Business Overview

11.3.3 Inovio Pharmaceuticals Covid-19 Vaccine Introduction

11.3.4 Inovio Pharmaceuticals Revenue in Covid-19 Vaccine Business (2017-2022)

11.3.5 Inovio Pharmaceuticals Recent Developments

11.4 Shenzhen Geno-Immune Medical Institute

11.4.1 Shenzhen Geno-Immune Medical Institute Company Details

11.4.2 Shenzhen Geno-Immune Medical Institute Business Overview

11.4.3 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Introduction

11.4.4 Shenzhen Geno-Immune Medical Institute Revenue in Covid-19 Vaccine Business (2017-2022)

11.4.5 Shenzhen Geno-Immune Medical Institute Recent Developments

11.5 GlaxoSmithKine

11.5.1 GlaxoSmithKine Company Details

11.5.2 GlaxoSmithKine Business Overview

11.5.3 GlaxoSmithKine Covid-19 Vaccine Introduction

11.5.4 GlaxoSmithKine Revenue in Covid-19 Vaccine Business (2017-2022)

11.5.5 GlaxoSmithKine Recent Developments

11.6 Pfizer

11.6.1 Pfizer Company Details

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Covid-19 Vaccine Introduction

11.6.4 Pfizer Revenue in Covid-19 Vaccine Business (2017-2022)

11.6.5 Pfizer Recent Developments

11.7 Johnson＆Johnson

11.7.1 Johnson＆Johnson Company Details

11.7.2 Johnson＆Johnson Business Overview

11.7.3 Johnson＆Johnson Covid-19 Vaccine Introduction

11.7.4 Johnson＆Johnson Revenue in Covid-19 Vaccine Business (2017-2022)

11.7.5 Johnson＆Johnson Recent Developments

11.8 Heat Biologics

11.8.1 Heat Biologics Company Details

11.8.2 Heat Biologics Business Overview

11.8.3 Heat Biologics Covid-19 Vaccine Introduction

11.8.4 Heat Biologics Revenue in Covid-19 Vaccine Business (2017-2022)

11.8.5 Heat Biologics Recent Developments

11.9 Sanofi

11.9.1 Sanofi Company Details

11.9.2 Sanofi Business Overview

11.9.3 Sanofi Covid-19 Vaccine Introduction

11.9.4 Sanofi Revenue in Covid-19 Vaccine Business (2017-2022)

11.9.5 Sanofi Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer